UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TDAQ
8526
TappAlpha Innovation 100 Growth & Daily Income ETF
TDAQ
$332M
| $7.08K | ﹤0.01% |
301
+99
| +49% | +$2.5K |
2025 Q4
1 quarter
|
|
8527
Azitra
AZTR
$7.79M
| $7.07K | ﹤0.01% |
30,205
+29,207
| +2,927% | +$6.71K |
2024 Q4
5 quarters
|
|
8528
VerifyMe
VRME
$11.8M
| $7.06K | ﹤0.01% |
+871
| New | +$8.86K |
2025 Q4
1 quarter
|
|
8529
ImmuCell
ICCC
$87.2M
| $7.04K | ﹤0.01% |
1,113
-498
| -31% | -$3.19K |
2014 Q4
45 quarters
|
|
8530
Spero Therapeutics
SPRO
$73.4M
| $7.04K | ﹤0.01% |
3,009
-113,438
| -97% | -$269K |
2019 Q2
27 quarters
|
|
|
TSCV
8531
Thrivent Small Cap Value ETF
TSCV
$168M
| $7.02K | ﹤0.01% |
+251
| New | +$7.14K |
2026 Q1
0 quarters
|
|
|
EBIT
8532
Harbor Small Cap Earners ETF
EBIT
$11.3M
| $7.02K | ﹤0.01% |
+200
| New | +$7.11K |
2026 Q1
0 quarters
|
|
8533
Senti Biosciences Holdings
SNTI
$10.1M
| $7.01K | ﹤0.01% |
8,637
+4,108
| +91% | +$3.97K |
2025 Q4
1 quarter
|
|
8534
Enveric Biosciences
ENVB
$6.53M
| $7.01K | ﹤0.01% |
3,612
+717
| +25% | +$1.96K |
2024 Q1
8 quarters
|
|
|
TRIO
8535
MC Trio Equity Buffered ETF
TRIO
$122M
| $7.01K | ﹤0.01% |
+116
| New | +$7.13K |
2026 Q1
0 quarters
|
|
8536
AllianzIM U.S. Equity Buffer10 Feb ETF
FEBT
$161M
| $7K | ﹤0.01% |
187
+7
| +4% | +$269 |
2025 Q3
2 quarters
|
|
|
AEMS
8537
DELISTED
Anfield Enhanced Market ETF
AEMS
| $7K | ﹤0.01% |
698
+489
| +234% | +$5.14K |
2025 Q3
2 quarters
|
|
8538
Zedge
ZDGE
$45.2M
| $6.96K | ﹤0.01% |
2,377
+2,364
| +18,185% | +$7.63K |
2025 Q3
2 quarters
|
|
8539
Global X MSCI Vietnam ETF
VNAM
$34.1M
| $6.96K | ﹤0.01% |
+305
| New | +$7.4K |
2026 Q1
0 quarters
|
|
|
JUNP
8540
PGIM US Large-Cap Buffer 12 ETF - June
JUNP
$95.8M
| $6.92K | ﹤0.01% |
+228
| New | +$6.99K |
2026 Q1
0 quarters
|
|
8541
ProShares UltraShort Energy
DUG
$38.2M
| $6.91K | ﹤0.01% |
411
+252
| +158% | +$5.77K |
2025 Q3
2 quarters
|
|
8542
MIRA Pharmaceuticals
MIRA
$30.4M
| $6.91K | ﹤0.01% |
6,456
+3,756
| +139% | +$4.71K |
2025 Q2
3 quarters
|
|
8543
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$65M
| $6.9K | ﹤0.01% |
145
+33
| +29% | +$1.58K |
2025 Q1
4 quarters
|
|
8544
Kurv Yield Premium Strategy Netflix (NFLX) ETF
NFLP
$4.55M
| $6.87K | ﹤0.01% |
260
+141
| +118% | +$3.52K |
2025 Q4
1 quarter
|
|
|
NSRX
8545
Nasus Pharma
NSRX
$44.7M
| $6.87K | ﹤0.01% |
3,094
+2,716
| +719% | +$14K |
2025 Q3
2 quarters
|
|
8546
Roundhill Metaverse ETF
METV
$225M
| $6.87K | ﹤0.01% |
431
-1,031
| -71% | -$17.9K |
2021 Q4
17 quarters
|
|
8547
Innovator Growth-100 Power Buffer ETF July
NJUL
$284M
| $6.86K | ﹤0.01% |
96
+23
| +32% | +$1.67K |
2024 Q4
5 quarters
|
|
8548
Iveda Solutions
IVDA
$3.74M
| $6.85K | ﹤0.01% |
+26,659
| New | +$14.3K |
2026 Q1
0 quarters
|
|
|
FMY
8549
First Trust Mortgage Income Fund
FMY
$46.7M
| $6.85K | ﹤0.01% |
582
+581
| +58,100% | +$6.98K |
2014 Q4
45 quarters
|
|
8550
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$175M
| $6.83K | ﹤0.01% |
+122
| New | +$8.04K |
2026 Q1
0 quarters
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.